Loading…

AGEs induce endothelial cells senescence and endothelial barrier dysfunction via miR-1-3p/MLCK signaling pathways

•Advanced-glycation end products treatment aggregated endothelial cell senescence process in human umbilical vein endothelial cells.•Advanced-glycation end products damaged endothelial barrier function.•Overexpression of miRNA-1-3p ameliorated endothelial barrier dysfunction and senescence induced b...

Full description

Saved in:
Bibliographic Details
Published in:Gene 2023-01, Vol.851, p.147030-147030, Article 147030
Main Authors: Cheng, Mian, Yang, Zhen, Qiao, Lifen, Yang, Yi, Deng, Yulei, Zhang, Cuntai, Mi, Tao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Advanced-glycation end products treatment aggregated endothelial cell senescence process in human umbilical vein endothelial cells.•Advanced-glycation end products damaged endothelial barrier function.•Overexpression of miRNA-1-3p ameliorated endothelial barrier dysfunction and senescence induced by advanced-glycation end products. Advanced glycation end products (AGEs) disturb endothelial barrier function and contribute to age-related diseases. As microRNAs (miRNAs) are potential therapeutic agents, targeting AGEs-associated signaling using miRNAs in endothelial cells may be an effective intervention strategy for age-related vascular disorders. This study investigated the effects of AGEs on the endothelial cell senescence and barrier function in human umbilical vein endothelial cells (HUVECs). HUVECs were treated with AGEs and transfected with miRNA-1-3p mimics to induce overexpression of miR-1-3p. Senescence-associated β-galactosidase (SA-β-Gal) staining and senescence-related proteins P53, P21, and P16 were detected to evaluate the endothelial cell senescence. The expression levels of myosin light chain kinase (MLCK) signaling and transendothelial electric resistance (TEER) were used to indicate endothelial barrier function. AGEs significantly increased SA-β-gal staining-positive cells accompanied by the upregulation of P53, P21, and P16 expression. AGEs also damaged endothelial barrier function by decreasing TEER and increasing zonula occludens protein 1, p-MLC/MLC, and MLCK. miRNA-1-3p was significantly reduced in HUVECs treated with AGEs. miR-1-3p overexpression decreased MLCK signal and improved AGEs-induced endothelial barrier function impairment. Meanwhile, miR-1-3p overexpression ameliorated oxidative stress and endothelial cell senescence induced by AGEs. AGEs induced endothelial cell senescence and endothelial barrier dysfunction by regulating miR-1-3p/MLCK signaling pathway.
ISSN:0378-1119
1879-0038
DOI:10.1016/j.gene.2022.147030